Human trial

Effects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes

Graphical abstract from Endocrinology, Diabetes & Metabolism — Graphical abstractZimmer et al.

Endocrinology, Diabetes & Metabolism

The paper

Katja B. Zimmer, Arne Gessner, Dennis Kannenkeril,

Agnes Bosch, Armin Ströbel, Roland Erich Schmieder,

Friedrich-Alexander-Universität Erlangen-Nürnberg

Endocrinology, Diabetes & Metabolism · 1 Oct 2026

doi.org/10.1002/edm2.70318 PubMed 42817074